OUTCOMES HIGHLIGHTS:

– The Revenue for the 6 months ended 30 June 2026 was around HK$ 2,032.5 million, representing a boost of around 10.8% as compared to the very same duration in 2025. The development in earnings was mostly attributable to the ongoing natural development of the Group– driven by the speeding up adoption of digitalization throughout the international oral market, especially in Europe and Australia– along with the stabilization and functional turn-around of the Mainland China market. This growth was partly balanced out by a profits decrease in North America, which was affected by a softer macroeconomic environment impacting high-value discretionary treatments, along with management’s tactical choice to justify loss-making Dental Service Organization (DSO) accounts to enhance consumer mix and safeguard margins.

– The Gross Profit Margin for the 6 months ended 30 June 2026 was roughly 58.1%; the gross revenue was roughly HK$ 1,180.9 million, showing a boost of roughly 17.4% as compared to the exact same duration in 2025.

– The Group’s EBITDA for the 6 months ended 30 June 2026 was roughly HK$ 560.7 million, representing a boost of roughly 22.8% as compared to the exact same duration in 2025.

– The Group’s Net Profit for the 6 months ended 30 June 2026 was roughly HK$ 377.6 million, representing a boost of 30.8% as compared to the exact same duration in 2025.

– Basic incomes per share for the 6 months ended 30 June 2026 totaled up to HK40.07 cents, representing a boost of around 31.9% as compared to the exact same duration in 2025.

– The Board stated an interim dividend of HK14.0 cents per regular share for the 6 months ended 30 June 2026.

EXTRA HIGHLIGHTS:

– For the 6 months ended 30 June 2026, the Group’s digital service cases that are produced from its Mainland China, Thailand and Vietnam production centers increased to around 627,773 cases, showing a boost of 29.2% as compared to the exact same duration in 2025 as an outcome of our customers’ ongoing adoption of intra-oral scanners.

HONG KONG, August 28, 2026 – (ACN Newswire) –27 August 2026, Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600. HK)a leading international oral prosthetic gadget company, is delighted to reveal the unaudited interim outcomes for the 6 months ended 30 June, 2026 (“the Period”).

In the very first half of 2026, the international macroeconomic environment stays unsure, with geopolitical stress and possible tariff modifications continuing to produce headwinds. The Group’s geographically varied production footprint and international circulation network position us highly to browse these obstacles. Unlike lots of rivals reliant on single-country production, our operations throughout China, Vietnam and Thailand (consisting of the recently gotten Hexa Ceram) supply remarkable durability and versatility. This method, integrated with our capability to adjust rapidly to regional market conditions, allows the Group to reduce threats and capitalise on chances throughout areas.

The oral market has actually continued to show amazing durability, underpinned by irreparable group patterns, consisting of aging populations and increasing awareness of oral health, which drive constant long-lasting need. Structure on our well efficiency, the Group is well positioned to sustain momentum and more enhance its market management.

Digitalisation stays a permanent market pattern that is speeding up debt consolidation of the oral prosthetics market. We are at the leading edge of this change, with digital option cases now representing roughly 35– 43% of overall volume. Our central digital workflows, intra-oral scanner collaborations, exclusive options and worldwide education centers have actually improved functional performance, lowered turn-around times and provides remarkable client experiences. These efforts develop high entry barriers and will continue to drive margin growth and market share gains in the coming years.

European Businesses

Throughout the duration under evaluation, the European market tape-recorded a profits of around HK$ 1,093.3 million, representing a boost of roughly HK$ 173.0 million as compared to the 6 months ended 30 June 2025. This geographical market represented roughly 53.8% of the Group’s overall profits. The boost of profits from the European market was attributable to the boost in sales order volume driven by the launch of brand-new items, such as digital dentures, and our advanced digital workflows.

North American Businesses

Throughout the duration under evaluation, the North American market tape-recorded an earnings of roughly HK$ 331.3 million, representing a decline of roughly HK$ 34.4 million as compared to the 6 months ended 30 June 2025. This geographical market represented around 16.3% of the Group’s overall profits.

The top-line contraction in North America was mainly driven by a softer macroeconomic environment, which briefly weighed on customer belief and need for high-value discretionary cosmetic treatments. In action, management proactively started a tactical justification of loss-making Dental Service Organization (DSO) accounts focused on enhancing the consumer mix, safeguarding gross margins, and focusing resources on higher-margin accounts.

Simultaneously, the Group’s varied production footprint throughout the United States, China, Vietnam, and Thailand continues to pay for considerable supply chain dexterity to browse trade and tariff intricacies– an essential differentiator in the market. Showing the durability of this technique, our United States import service system provided a 1.4% period-on-period sales development in the very first half of 2026. This efficiency highlights how the speeding up pattern towards scientific digitalization and the cost-competitiveness of our imported line of product have actually successfully alleviated and balanced out the effect of United States tariffs.

Greater China Businesses

Throughout the duration under evaluation, the Greater China market tape-recorded an income of around HK$ 300.0 million, representing a boost of roughly HK$ 6.8 million as compared to 6 months ended 30 June 2025. This geographical market represented roughly 14.8% of the Group’s overall income.

Regional efficiency showed diverging market characteristics throughout areas. In regional currency terms, sales in Mainland China increased by around 0.9% year-on-year, signalling that the marketplace has actually mostly bottomed out from the preliminary effect of Volume-Based Procurement (VBP) policies and extended rate competitors. To secure sustainable success, the Group intentionally rotated far from low-margin sections to concentrate on serving mid- to high-value clients. On the other hand, sales in the Hong Kong market reduced by around 8.5% in regional currency year-on-year. This contraction was mostly driven by a short-term decrease in regional client gos to, as cross-border oral usage increased due to aggressive promos for oral treatments provided by Mainland China centers targeting Hong Kong homeowners.

Regardless of these near-term shifts, the Group stays positive about the mid- to long-lasting outlook for the Greater China area. Federal government procurement procedures in Mainland China are anticipated to standardize prosthetic prices and boost market openness, developing a more equal opportunity where the Group’s leading brand name track record, production scale, and functional effectiveness act as unique competitive benefits. To catch developing market need, the Group is actively broadening its item portfolio, especially in mid-end offerings and items.

Australian Businesses

Throughout the duration under evaluation, the Australian market tape-recorded an income of around HK$ 162.8 million, representing a boost of roughly HK$ 24.9 million as compared to the 6 months ended 30 June 2025. This geographical market represented around 8.0% of the Group’s overall earnings. The boost in income from Australia was mostly driven by strong adoption of digital oral items and anti-snoring gadgets, and wins in oral service company (DSO) consumers.

Other Markets

Other markets mostly consist of Indian Ocean nations, Malaysia, Taiwan, Singapore and Thailand. For the 6 months ended 30 June 2026, these markets tape-recorded an income of around HK$ 145.2 million, representing a boost of roughly HK$ 27.4 million as compared to the 6 months ended 30 June 2025. This geographical market represented around 7.1% of the Group’s overall profits. The boost in income from Other markets was mainly driven by the strong income contributions from Thailand, Singapore and Malaysia. The scaled production centers in Thailand and Vietnam have actually improved local supply performance, expanded item schedule, and reinforced the Group’s competitive footprint in the area.

Future Prospects and Strategies

Looking ahead, the Group stays dedicated to strengthening its around the world leading position through a multi-dimensional technique. We will continue to pursue selective acquisitions, joint endeavors and collaborations to broaden and match our item offerings, especially in our high-growth clear aligner, Trioclear, while reinforcing our circulation and sales networks. Continuous financial investments in mass-scale production centers, AI, automation, research study and advancement, and digital development will drive effectiveness gains and protect our position at the leading edge of the market.

With the Board’s substantial experience and sensible governance, the Group is well placed to take brand-new organization chances while staying rigorous monetary discipline to secure Shareholders’ interests. The Board reveals its genuine thankfulness to our devoted staff members, devoted clients, providers, and organization partners for their undeviating dedication. Their cumulative efforts have actually contributed in providing another year of record outcomes and will continue to support the Group’s long-lasting success.

Modern Dental Group has a worldwide portfolio of highly regarded brand names, consisting of Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, Apex Digital Dental in Malaysia and Hexa Ceram in Thailand. We have actually grown these brand names by supplying premium and constant quality items and remarkable client service. We have more than 80 service centers in over 30 nations and serve over 35,000 consumers.

Subject: Press release summary